Nicoretteicy (Nicotine)

Nicotine in Nicoretteicy binds to nicotinic acetylcholine receptors in the brain, especially the α4β2 subtype. This activation provides a mild stimulant effect that eases withdrawal, allowing the smoker to gradually lower nicotine dependence while avoiding the harmful constituents of tobacco smoke.

The appropriate dose of Nicoretteicy is determined by the prescribing clinician based on the individual’s smoking history, level of dependence, and any underlying health conditions. Patients should follow the healthcare professional’s instructions and not exceed the recommended amount.

Safety of Nicoretteicy in pregnancy or while breastfeeding has not been established. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made in consultation with a qualified healthcare provider.

To order Nicoretteicy, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nicoretteicy delivers nicotine via the oral mucosa, offering rapid absorption and flexible dosing compared with transdermal patches, which provide steady release over 24 hours. Unlike inhalers, it does not mimic the hand‑to‑mouth ritual of smoking, which may be advantageous for some users seeking a discreet cessation aid.

Store Nicoretteicy at ambient temperature below 25 °C, in its original packaging, protected from moisture, direct sunlight, and extreme heat. Keep the product out of reach of children and do not use if the packaging is damaged or the product appears discoloured.

Nicoretteicy is placed in the mouth and allowed to dissolve slowly against the oral mucosa. Users should avoid chewing or swallowing the product whole, and should not eat or drink for a few minutes after administration to ensure optimal nicotine absorption.

Serious risks include allergic reactions such as rash, swelling, or difficulty breathing, as well as cardiovascular events like chest pain, irregular heartbeat, or hypertensive crisis. Users experiencing any of these symptoms should discontinue use immediately and seek medical attention.

Nicoretteicy is not recommended for individuals under 18 years of age, for those with recent myocardial infarction or unstable cardiovascular disease without medical supervision, and for pregnant or breastfeeding women unless a healthcare professional determines the benefits outweigh the risks.